Search

Author/Creator de Jong, Jan

1. A drug–drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies. Issue 12 (2nd December 2018)

Authors:
de Jong, Jan; Hellemans, Peter; De Wilde, Severijn; Patricia, Daniel; Masterson, Tara; Manikhas, Georgii; Myasnikov, Alexander; Osmanov, Dzhelil; Córdoba, Raúl; Panizo, Carlos; de Zwart, Loeckie; Snoeys, Jan; Chauhan, Vijay; Jiao, James; Sukbuntherng, Juthamas; Ouellet, Daniele
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 12(2018)
Page Start:
2888
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study. (2020)

Authors:
Schaffer, Michael; Chaturvedi, Shalini; Davis, Cuc; de Jong, Jan; Aquino, Regina; Oki, Yasuhiro; Fourneau, Nele; Younes, Anas; Balasubramanian, Sriram
Journal:
Cancer treatment and research communications
Issue:
Number 25(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. FSAP‐mediated nucleosome release from late apoptotic cells is inhibited by autoantibodies present in SLE. Issue 3 (22nd December 2015)

Authors:
Marsman, Gerben; Stephan, Femke; de Leeuw, Karina; Bulder, Ingrid; Ruinard, Jessica T.; de Jong, Jan; Westra, Johanna; Bultink, Irene E.M.; Voskuyl, Alexandre E.; Aarden, Lucien A.; Luken, Brenda M.; Kallenberg, Cees G.M.; Zeerleder, Sacha
Journal:
European journal of immunology
Issue:
Volume 46:Issue 3(2016)
Page Start:
762
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6. Issue 5 (18th September 2020)

Authors:
de Jong, Jan; Mitselos, Anna; Jurczak, Wojciech; Cordoba, Raul; Panizo, Carlos; Wrobel, Tomasz; Dlugosz‐Danecka, Monika; Jiao, James; Sukbuntherng, Juthamas; Ouellet, Daniele; Hellemans, Peter
Journal:
Pharmacology research & perspectives
Issue:
Volume 8:Issue 5(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Needs for information and reasons for (non)adherence in chronic myeloid leukaemia: Be aware of social activities disturbing daily routines. (17th September 2018)

Authors:
Boons, Christel C. L. M.; Harbers, Lorette; Timmers, Lonneke; de Jong, Jan; Swart, Eleonora L.; Harry Hendrikse, N.; Janssen, Jeroen J. W. M.; Hugtenburg, Jacqueline G.
Journal:
European journal of haematology
Issue:
Volume 101:Number 5(2018)
Page Start:
643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma. Issue 1 (19th June 2017)

Authors:
Huang, Shang‐Yi; Chang, Cheng‐Shyong; Liu, Ta‐Chih; Wang, Po‐Nan; Yeh, Su‐Peng; Ho, Ching‐Liang; Kuo, Ming‐Chung; Lin, Hsuan‐Yu; de Jong, Jan; Chen, Jia‐Yi; Yang, Ya‐Wen
Journal:
Hematological oncology
Issue:
Volume 36:Issue 1(2018)
Page Start:
238
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗